Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 107, Issue 31, Pages 13824-13829
Publisher
Proceedings of the National Academy of Sciences
Online
2010-07-15
DOI
10.1073/pnas.1008051107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
- (2009) U. Keilholz et al. BLOOD
- Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination
- (2009) Jon Amund Kyte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Clinical Considerations in Developing Dendritic Cell Vaccine Based Immunotherapy Protocols in Cancer
- (2009) Vedang Murthy et al. CURRENT MOLECULAR MEDICINE
- Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial
- (2009) Ann Van Driessche et al. CYTOTHERAPY
- Dendritic Cell-Based Cancer Gene Therapy
- (2009) Evelien L.J.M. Smits et al. HUMAN GENE THERAPY
- WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor
- (2009) Yusuke Oji et al. INTERNATIONAL JOURNAL OF CANCER
- Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by StandardizedWT1Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
- (2009) Daniela Cilloni et al. JOURNAL OF CLINICAL ONCOLOGY
- WT1 mRNA Level in Peripheral Blood Is a Sensitive Biomarker for Monitoring Minimal Residual Disease in Acute Myeloid Leukemia
- (2009) Yuichi Sakamoto et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow
- (2008) J. J. Melenhorst et al. BLOOD
- Dendritic cell vaccination and immune monitoring
- (2008) E. H. J. G. Aarntzen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
- (2008) J. Greiner et al. CLINICAL CANCER RESEARCH
- WT1 peptide vaccine for the treatment of cancer
- (2008) Yoshihiro Oka et al. CURRENT OPINION IN IMMUNOLOGY
- Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives
- (2008) M. A. Sekeres HAEMATOLOGICA
- Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy
- (2008) D. Cilloni et al. HAEMATOLOGICA
- Cancer Immunotherapy by Dendritic Cells
- (2008) Cornelis J.M. Melief IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started